Carrie Smith Cox

TXN Director Carrie Smith Cox sells 8,838 shares for $2.7M as stock trades -0.4% from 52-week high

Carrie Smith Cox, a Director at Texas Instruments, sold 8,838 shares across four transactions on 2026-05-13 for total proceeds of $2,708,028.73, while the stock sits just -0.4% from its 52-week high and has surged +40.8% over the past 30 days. The sale comes against a backdrop of strong momentum but leaves Cox with 37,626 shares post-transaction, indicating continued meaningful exposure to TXN. Her cross-ticker track record includes only 1 prior sell with no measurable 90-day outcome, so there is insufficient historical data to assess her sell-timing accuracy. With TXN trading at a P/E of 52.23 and annual revenue growth of +13.0%, the elevated valuation context may be relevant to how investors interpret the timing of this disposal near the stock's 52-week peak.

Executive Chair Carrie Smith buys 65,400 shares of Organon (OGN) at $7.67 on 2025-11-12, increasing holdings 524.5% to 77,869 shares total.

Carrie Smith, Executive Chair of Organon, purchased 65,400 shares for $501,755.34 at $7.67, a substantial increase from her prior holdings of 12,469 shares. The transaction occurred as the stock trades at $7.62, down 53.6% from its 52-week high of $16.41 and down 20.3% over the prior 30 days. This marks Smith's second buy at Organon; her prior purchase on 2025-05-14 posted a 90-day return of +12.2%, establishing a pattern of well-timed entry at this ticker. The company's P/E of 3.95 paired with $160.0M in net income on $1.6B in quarterly revenue reflects a financially stable but structurally compressed valuation. The significant share accumulation, combined with her track record of profitable buys at this same ticker, suggests deliberate capital allocation during a period of substantial price weakness relative to recent highs.

Director Cox Smith buys 12,469 shares of OGN at $8.07; 5 other insiders also bought within 14 days amid 61.9% decline from 52-week high.

Director Carrie Smith purchased 12,469 shares at $8.07 on 2025-05-14, establishing a new position worth $100,591.16. This transaction occurs alongside a coordinated cluster pattern: 5 other insiders also bought OGN within the past 14 days. The timing occurs in a depressed price environment—OGN is trading $8.77, which is 61.9% below its 52-week high of $23.03, with a steep 90-day decline of 42.6%. The company trades at a low P/E of 3.03 with positive fundamentals including $1.5B in quarterly revenue and $87.0M net income (annual revenue growth of 2.2%). The coordinated buying pattern and founder-level purchasing into a severely drawdown stock warrant attention as a potential signal of conviction, though the actual motivation and forward intent cannot be inferred from transaction data alone.